Product compounding quality issue
(UMLS:C2609230)
- UMLS ID:
- C2609230
- MeSH ID:
- N/A
Synonym(s)
1.
Product compounding quality issue
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Exenatide | FAERS: 9 | US FAERS | |
| 2 | Clonidine | FAERS: 7 | US FAERS | |
| 3 | Triamcinolone | FAERS: 5 | US FAERS | |
| 4 | Baclofen | FAERS: 3 | US FAERS | |
| 5 | Calcium Gluconate | FAERS: 3 | US FAERS | |
| 6 | Citrulline | FAERS: 3 | US FAERS | |
| 7 | Naltrexone | FAERS: 3 | US FAERS | |
| 8 | Clonidine | FAERS: 2 | US FAERS | |
| 9 | Deferoxamine | FAERS: 2 | US FAERS | |
| 10 | Triiodothyronine | FAERS: 2 | US FAERS | |
| 11 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 12 | Alprazolam | FAERS: 1 | US FAERS | |
| 13 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 1 | US FAERS | |
| 14 | Atenolol | FAERS: 1 | US FAERS | |
| 15 | Azithromycin | FAERS: 1 | US FAERS | |
| 16 | Bupivacaine | FAERS: 1 | US FAERS | |
| 17 | Ceftriaxone | FAERS: 1 | US FAERS | |
| 18 | Clarithromycin | FAERS: 1 | US FAERS | |
| 19 | Diltiazem | FAERS: 1 | US FAERS | |
| 20 | Diltiazem | FAERS: 1 | US FAERS | |
| 21 | Dobutamine | FAERS: 1 | US FAERS | |
| 22 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 23 | Fentanyl | FAERS: 1 | US FAERS | |
| 24 | Fluocinonide | FAERS: 1 | US FAERS | |
| 25 | Glycopyrrolate | FAERS: 1 | US FAERS | |
| 26 | Hydrocortisone | FAERS: 1 | US FAERS | |
| 27 | Lansoprazole | FAERS: 1 | US FAERS | |
| 28 | Lenalidomide | FAERS: 1 | US FAERS | |
| 29 | Leuprolide | FAERS: 1 | US FAERS | |
| 30 | Lidoderm | FAERS: 1 | US FAERS | |
| 31 | Linezolid | FAERS: 1 | US FAERS | |
| 32 | Lisinopril | FAERS: 1 | US FAERS | |
| 33 | Lorazepam | FAERS: 1 | US FAERS | |
| 34 | Magnesium Sulfate | FAERS: 1 | US FAERS | |
| 35 | Maloprim | FAERS: 1 | US FAERS | |
| 36 | Methotrexate | FAERS: 1 | US FAERS | |
| 37 | Methyltestosterone | FAERS: 1 | US FAERS | |
| 38 | Mometasone Furoate | FAERS: 1 | US FAERS | |
| 39 | Morphine | FAERS: 1 | US FAERS | |
| 40 | Omeprazole | FAERS: 1 | US FAERS | |
| 41 | Pregabalin | FAERS: 1 | US FAERS | |
| 42 | Progesterone | FAERS: 1 | US FAERS | |
| 43 | Risperidone | FAERS: 1 | US FAERS | |
| 44 | Ropivacaine | FAERS: 1 | US FAERS | |
| 45 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 46 | Tacrolimus | FAERS: 1 | US FAERS | |
| 47 | Terazosin | FAERS: 1 | US FAERS | |
| 48 | Thyroxine | FAERS: 1 | US FAERS | |
| 49 | Vancomycin | FAERS: 1 | US FAERS | |
| 50 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 51 | hydroquinone | FAERS: 1 | US FAERS | |
| 52 | mecobalamin | FAERS: 1 | US FAERS | |
| 53 | reviparin | FAERS: 1 | US FAERS | |
| 54 | soybean oil, phospholipid emulsion | FAERS: 1 | US FAERS | |
| 55 | Esomeprazole | Canada Vigilance: 1 | Canada Vigilance | |
| 56 | Estradiol | Canada Vigilance: 1 | Canada Vigilance | |
| 57 | Magnesium;5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide;trihydrate | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.